Deciding how to treat a condition like high cholesterol can be tough, especially when some treatment options have been tied to an increased risk of other health problems.

To reduce the risk of heart disease in people with diabetes, doctors often prescribe drugs to lower cholesterol. However, these drugs could do more harm than good for some patients.

A drug that would have been a combination treatment for diabetes and high cholesterol will no longer be developed, according to an article in the Wall Street Journal.

Metabolic syndrome is the name for a group of factors that boost the risk of heart disease and diabetes. Now, it seems metabolic syndrome may also be linked to the "wear-and-tear" of arthritis.

The practice of blood-letting or bleeding patients was abandoned in the 19th  century when it became clear there was little benefit. New research suggests the barbaric-sounding practice could offer a very real heart benefit.

A soaring increase in the number of teenagers suffering from diabetes means that more than a third of presumably healthy normal-weight adolescents are at risk of heart disease.

An effective option for aiding high-risk patients suffering from cardiovascular disease may be an individualized treatment plan from a nurse-led team focused on reducing heart disease risk factors.

The FDA has approved Juvisync, a prescription medication that contains two previously approved medicines in one tablet: Januvia (sitagliptin) for diabetes and Zocor (simvastatin) for high cholesterol.

Some obese patients develop conditions such as heart disease and diabetes, while others manage to avoid such chronic diseases. That may be because all obesity is not the same.

Not all fat is created equal, especially when it comes to men with excessive weight around the middle. Some with added belly fat may be at an increased risk of developing heart disease and other serious health problems.